MedTrace Logo

VATS Major Lung Resection for Chinese Early-stage Non-small Cell Lung Cancer

NCT01707888 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 500

Last updated 2015-01-27

No results posted yet for this study

Summary

Surgery may be the best treatment choice for early stage non-small cell lung cancer. And VATS major lung resection have been preferred as a standard radical procedure for early stage non-small cell lung cancer (NSCLC).This study aim to investigate the outcome of VATS major lung resection for lung cancer as a real-world study in china.

Conditions

Interventions

PROCEDURE

Thoracoscopy/VATS

Patients undergo major lung resection by thoracoscopic surgery or video assisted thoracoscopic surgery.

Sponsors & Collaborators

  • Peking University People's Hospital

    lead OTHER

Principal Investigators

  • Jun Wang, MD · Peking University People's Hospital

  • Fan Yang, MD · Peking University People's Hospital

  • Zhao Xi Sui, MD · Peking University People's Hospital

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-09-30
Primary Completion
2017-06-30
Completion
2017-06-30

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01707888 on ClinicalTrials.gov